诺思格股价涨5.35%，西藏东财基金旗下1只基金重仓，持有1.24万股浮盈赚取3.89万元

Group 1 - Norsg's stock price increased by 5.35% on September 10, reaching 61.80 CNY per share, with a trading volume of 263 million CNY and a turnover rate of 7.73%, resulting in a total market capitalization of 5.969 billion CNY [1] - The stock has risen for eight consecutive days, with a cumulative increase of 13.95% during this period [1] - Norsg (Beijing) Pharmaceutical Technology Co., Ltd. specializes in clinical trial operation services, clinical trial site management services, biological sample testing services, data management and statistical analysis services, clinical trial consulting services, and clinical pharmacology services [1] Group 2 - The East Finance Growth Mixed Fund A (018088) holds 12,400 shares of Norsg, accounting for 4.85% of the fund's net value, making it the fifth-largest holding [2] - The fund has generated a floating profit of approximately 38,900 CNY today and 89,000 CNY during the eight-day rising period [2] - The fund was established on April 11, 2023, with a latest scale of 9.6956 million CNY and has achieved a year-to-date return of 47.97% [2]